Market Tracker

01/30 6:05pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

56.92
Data as of Jan 30
 -0.11 / -0.19%
Today’s Change
41.99
Today|||52-Week Range
80.42
+6.97%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close57.03
Today’s open56.93
Day’s range55.33 - 58.66
Volume309,088
Average volume (3 months)272,339
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+69.17%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio172.5
Price/Sales21.82
Price/Book23.53

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.17+0.69%
ARNAArena Pharmaceutical...-0.20-4.43%
EBSEmergent BioSolution...-0.77-2.67%
TTPHTetraphase Pharmaceu...-1.71-4.49%
Data as of 4:04pm ET, 01/30/2015

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)$0.60
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts